protein

Phosphodiesterase 5A, Recombinant, Mouse (Phosphodiesterase 5A cGMP-specific, PDE5A, CGB-PDE, cGMP-binding cGMP-specific phosphodiesterase, cGMP-specific 3',5'-cyclic phosphodiesterase, CN5N, Pde5, PDE5A1)

MBS635586

0.005 mg

730 USD

Recombinant Protein

Phosphodiesterase 5A, Recombinant, Mouse (Phosphodiesterase 5A cGMP-specific, PDE5A, CGB-PDE, cGMP-binding cGMP-specific phosphodiesterase, cGMP-specific 3',5'-cyclic phosphodiesterase, CN5N, Pde5, PDE5A1)

[Phosphodiesterase 5A]

[phosphodiesterase 5A; cGMP-specific 3',5'-cyclic phosphodiesterase; cGMP-specific 3',5'-cyclic phosphodiesterase; phosphodiesterase isozyme 5; cGMP-specific phosphodiesterase PDE5A2; cGMP-specific phosphodiesterase type 5A; cGMP-binding cGMP-specific 3',5'-cyclic nucleotide phosphodiesterase; phosphodiesterase 5A, cGMP-specific; cGMP-binding cGMP-specific phosphodiesterase]

[PDE5A; PDE5A; CN5A; PDE5; CGB-PDE; PDE5; CGB-PDE]

PDE5A_HUMAN

Purified. 0.7

Supplied as a liquid in 45mM Tris HCL, p.H. 8.0, 124mM sodium chloride, 2.4mM KCL, 3mM DTT, 18mM glutathione, and 10% glycerol

0.34mg/ml

Aliquot to avoid repeated freezing and thawing and store at -70°C. Aliquots are stable for 6 months after receipt. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

Useful for the study of enzyme kinetics, screening inhibitors, and selectivity profiling. Other applications not tested. Optimal dilution determined by the researcher.

Testing Data

Testing Data

Source: Full length recombinant mouse PDE5A with an N-terminal GST tag, expressed in an Baculovirus infected Sf9 cell expression system. Specific Activity: 4630pmol/min/ug. Unit Definition: 1 unit is defined as the amount of enzyme that will convert 1 pmole of 3', 5'-cGMP to 5' GMP per minute at 37°C. Assay Conditions: 10mM Tris-HCl, pH 7.4, 10mM MgCl2, 1mM MnCl2, 0.1mg/ml BSA, 200uM cGMP, 2.5kU 5' nucleotidase, 37°C, 20 minutes.

Molecular Biology; MB-Enzymes, Phosphodiesterase

The cyclic monophosphate nucleotides (cyclic adenosine monophosphate [cAMP] and cyclic guanosine monophosphate [cGMP]) are found ubiquitously in mammalian cells and act as second messenger transducers to effect the intracellular actions of a variety of G protein coupled receptors (GPCRs) for hormones, cytokines, and neurotransmitters. Cyclic nucleotides are important intracellular second messengers which play important role in a variety of signal transduction process. The cyclic nucleotides are hydrolyzed and compartmentalized by a family of enzymes called phosphodieterases. One of the many phosphodiesterases that compartmentalized and hydrolyze cGMP in various tissues is phosphodiesterase type 5A (PDE5A). The cGMP is involved in nitric oxide signaling as well as cell signaling associated with natriuretic peptides and gulanylins. Some of the intracellular biding cites for the cGMP include cyclic nucleotide gated ion channels, cGMP dependent protein kinases, and cyclic GMP biding phosphodiesterases (cGB PDEs). The cGB PDEs include PDE2, PDE3, PDE5, PDE5 and PDE10; the members of these families contain various structural and functional motifs that are conserved. Most of these proteins contain dimeric subunits that contain a highly conserved cGMP binding site and a phosphodiesterase catalytic site. The cGMP specific phosphodiesterase type 5A (PDE5A) family is comprised of 2 genes (PDE5A and PDE5B) each with multiple splice variants generated by RNA splicing and use of alternate initiation sites. The PDE5 is highly expressed in aorta and lungs, intestine, kidney adrenal gland cerebellum and cerebrum. In cerebellum the PDE5 is highly expressed during neonatal development in Purkinge cells layer. The PDE5 is also abundant in vascular smooth muscle regulating cGMP levels and vascular smooth muscle tonicity. In corpus cavernosum inhibition of PDE5 by sildenafil corrects erectile dysfunctions. The nitric oxide donor sodium notropurside (SNP) stimulate PDE5 activity by cGMP dependent kinase phosphorylation. PDE5A1 has 875 amino acids (99.5 kDa). The amino terminal 142aa of the PDE5 gene showed no sequence homology with other PDEs and also contained serine 92 that is phosphorylated by cGMP kinases. There is growing evidence that supports important roles for PDE5A in both the vasculature and heart.

30267899

AAP21809.1

O76074

124kD

Hemostasis Pathway (106028); Nitric Oxide Stimulates Guanylate Cyclase Pathway (187200); Platelet Homeostasis Pathway (187198); Purine Metabolism Pathway (82944); Purine Metabolism Pathway (307); CGMP Effects Pathway (187201)

This gene encodes a cGMP-binding, cGMP-specific phosphodiesterase, a member of the cyclic nucleotide phosphodiesterase family. This phosphodiesterase specifically hydrolyzes cGMP to 5'-GMP. It is involved in the regulation of intracellular concentrations of cyclic nucleotides and is important for smooth muscle relaxation in the cardiovascular system. Alternative splicing of this gene results in three transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2008]

PDE5A: a cGMP-binding, cGMP-specific phosphodiesterase, a member of the cyclic nucleotide phosphodiesterase family. This phosphodiesterase specifically hydrolyzes cGMP to 5 -GMP. It is involved in the regulation of intracellular concentrations of cyclic nucleotides and is important for smooth muscle relaxation in the cardiovascular system. Phosphorylation is regulated by binding of cGMP to the two allosteric sites. Sildenafil (Viagra) is a highly selective and potent inhibitor of PDE5A. Alternative splicing results in four transcript variants encoding distinct isoforms. Protein type: Nucleotide Metabolism - purine; Phosphodiesterase; EC 3.1.4.35. Chromosomal Location of Human Ortholog: 4q27. Cellular Component: cytosol. Molecular Function: 3 ,5 -cyclic-GMP phosphodiesterase activity; metal ion binding; cGMP binding; 3 ,5 -cyclic-nucleotide phosphodiesterase activity. Biological Process: positive regulation of MAP kinase activity; negative regulation of T cell proliferation; regulation of cGMP metabolic process; cGMP catabolic process; blood coagulation; signal transduction

0.005 mg

730 USD